T Xue, P Luo, H Zhu, Y Zhao, H Wu, R Gai, Y Wu… - Toxicology and applied …, 2012 - Elsevier
Dasatinib, a multitargeted inhibitor of BCR–ABL and SRC kinases, exhibits antitumor activity
and extends the survival of patients with chronic myeloid leukemia (CML) and Philadelphia …